Article
Molecular markers in bladder cancer: Novel research frontiers
8 Jun 2015
Abstract excerpt
Bladder cancer (BC) is a heterogeneous disease encompassing distinct biologic features that lead to extremely different clinical behaviors. In the last 20 years, great efforts have been made to predict disease outcome and response to treatment by developing risk assessment calculators based on multiple standard clinical-pathological factors, as well as by testing several molecular markers. Unfortunately, risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
